RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 8, Pages 4188
Publisher
MDPI AG
Online
2021-04-19
DOI
10.3390/ijms22084188
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
- (2021) Shirin Hafezi et al. Cancers
- MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer
- (2019) Yiling Situ et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Predictive biomarkers for drug response in bladder cancer
- (2019) Takahiro Yoshida et al. INTERNATIONAL JOURNAL OF UROLOGY
- MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment
- (2019) Lei Bian et al. Molecular Cancer
- Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening
- (2018) Sebastien Rinaldetti et al. Oncotarget
- FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer
- (2018) Johannes Breyer et al. BJU INTERNATIONAL
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
- (2017) J. Alfred Witjes et al. EUROPEAN UROLOGY
- FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
- (2017) Sebastien Rinaldetti et al. Oncotarget
- Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis
- (2016) Ming Yin et al. ONCOLOGIST
- Cockayne syndrome group B protein regulates DNA double-strand break repair and checkpoint activation
- (2015) N. L. Batenburg et al. EMBO JOURNAL
- Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
- (2015) Elizabeth R. Plimack et al. EUROPEAN UROLOGY
- FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance
- (2014) Stefania Zona et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma
- (2014) E. M. Van Allen et al. Cancer Discovery
- Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials
- (2013) Jeffrey J. Leow et al. EUROPEAN UROLOGY
- Rad51 Paralog Complexes BCDX2 and CX3 Act at Different Stages in the BRCA1-BRCA2-Dependent Homologous Recombination Pathway
- (2012) J. Chun et al. MOLECULAR AND CELLULAR BIOLOGY
- Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition
- (2012) Francesca Cavallo et al. PLoS One
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- New Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine
- (2011) J. B. Shah et al. CLINICAL CANCER RESEARCH
- Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
- (2010) Ganesh V. Raj et al. CANCER
- Purified human BRCA2 stimulates RAD51-mediated recombination
- (2010) Ryan B. Jensen et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started